Health
Affinity’s COVID-19 antibodies ready for clinical trials – BSA bureau
The neutralizing antibodies under trial are potentially useful for vaccine development for an apid therapy or to protect people in high-risk situations such as healthcare workers or people in direct contact with COVID patients.

The neutralizing antibodies under trial are potentially useful for vaccine development for an apid therapy or to protect people in high-risk situations such as healthcare workers or people in direct contact with COVID patients.
Melbourne-based Affinity Biosciences Pty Ltd (Affinity) has lodged a pre-publication submission to the scientific journal, ‘mAbs’, detailing its results and observations relating to the discovery of potent antibodies against COVID-19.
This can be found at the link,’Anti…
-
General10 hours ago
Australian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News19 hours ago
Rainbow Beach surfer’s untold 7/7 story
-
Noosa News12 hours ago
Woman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
Noosa News10 hours ago
Woman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba